15,079 followers
Japanese study of risk of secondary primary malignancies (SPMs) in #myeloma patients with or without autologous stem cell transplantation finds survival benefit of receiving #Revlimid outweighed the increased risk of SPMs: https://t.co/dRGSVNkunN. https://